Dr Robin Hilsabeck is a board-certified clinical neuropsychologist who is Professor of Neurology and Division Chief of Clinical Neuropsychology at The University of Texas (UT) Health San Antonio and the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases. Previously, she was Director of the Comprehensive Memory Center, an interprofessional dementia specialty clinic, at UT Health Austin Mulva Clinic for the Neurosciences. Dr Hilsabeck's research has been funded by the National Institutes of Health, the Alzheimer's Association, and the Texas Alzheimer's Research and Care Consortium. She has over 80 publications and 130 workshop and conference presentations. Dr Gayle Ayers is Associate Professor in the Department of Psychiatry at Texas Tech University Health Sciences Center School of Medicine. She completed her psychiatry residency training at UT Southwestern in Dallas, TX, and a geriatric psychiatry fellowship at Yale University. She is board certified in both Adult andGeriatric Psychiatry. Dr Ayers previously worked for 8 years in Austin as an Assistant Professor in the both the Department of Psychiatry and Neurology at Dell Medical School and with Ascension Seton in Austin. She was the Medical Director for a geriatric clinic that served a broad Central Texas rural area. She has engaged in numerous talks and presentations to further community education regarding cognitive disorders.

• Introduction and OverviewRobin C. Hilsabeck and Gayle Ayers Section I: Core Concepts1. Epidemiology, Risk Factors, and Disease Burden Jason E. Schillerstrom, Kimberly S. Benavente, and Ivelisse M. Velazquez-Negron 2. Diagnostic Interviewing and Cognitive ScreeningPhillip K. Martin, Kamalakar Surineni, and Ryan W. Schroeder 3. Neuropsychological AssessmentGabrielle A. Hromas and Jeremy J. Davis 4. Neurologic Exam Sethulakshmi Sreevalsam Anil and Badr Ratnakaran 5. Neuroimaging Mary A. Kelley and John A. Bertelson 6. Differential Diagnosis Emily J. MacKillop and Heather E. McNeely Section II: Age-Associated Neurocognitive Disorders7. Mild Cognitive Impairment Alec Neale, Jenna Axelrod, Elizabeth Geary, and Leslie M. Guidotti-Breting 8. Alzheimer's Disease Kyle J. Jennette and Jason R. Soble 9. Vascular Disease Seetha Chandrasekhara and Danna L. Zevy 10. Frontotemporal Lobular Degeneration Angelina J. Polsinelli, Dale Korinek, Elizabeth K. Vernon, and Sophia Wang 11. Lewy Body Disease and Atypical Parkinsonian Conditions Bonnie M. Scott and Jared F. Benge 12. Rare and Rapidly Progressive Dementias Joel E. Kamper, Emily N. VanDerBleek, and Erin K. Bailey 13. Dementia due to Other Medical Conditions Channing A. Sofko and Katya Nama Section III: Disease Management14. Risk Management Aaron Bonner-Jackson 15. Pharmacological Treatment Deanna Fernandes and Josepha Cheong 16. Non-pharmacological Approaches - Yesenia Serrano, Marie C. Weil, and Stephanie A. Tuncel 17. Safety Considerations Joseph J. Asper, Alyssa C. Smith, Angelina J. Polsinelli, and Sophia Wang 18. Palliative and Advanced Care Planning Adithy S. Nagarajan, Brian Donley, and Erica C. Garcia-Pittman 19. Legal Issues Senthil Vel Rajan Rajaram Manoharan MBBS, Jessy Walia, and Mack Bozman 20. Attending to the Caregiver Shannon Reilly, Brianna Daranciang, and Kathleen Fuchs

Dr Robin Hilsabeck is a board-certified clinical neuropsychologist who is Professor of Neurology and Division Chief of Clinical Neuropsychology at The University of Texas (UT) Health San Antonio and the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases. Previously, she was Director of the Comprehensive Memory Center, an interprofessional dementia specialty clinic, at UT Health Austin Mulva Clinic for the Neurosciences. Dr Hilsabeck's research has been funded by the National Institutes of Health, the Alzheimer's Association, and the Texas Alzheimer's Research and Care Consortium. She has over 80 publications and 130 workshop and conference presentations. Dr Gayle Ayers is Associate Professor in the Department of Psychiatry at Texas Tech University Health Sciences Center School of Medicine. She completed her psychiatry residency training at UT Southwestern in Dallas, TX, and a geriatric psychiatry fellowship at Yale University. She is board certified in both Adult andGeriatric Psychiatry. Dr Ayers previously worked for 8 years in Austin as an Assistant Professor in the both the Department of Psychiatry and Neurology at Dell Medical School and with Ascension Seton in Austin. She was the Medical Director for a geriatric clinic that served a broad Central Texas rural area. She has engaged in numerous talks and presentations to further community education regarding cognitive disorders.

• Introduction and OverviewRobin C. Hilsabeck and Gayle Ayers Section I: Core Concepts1. Epidemiology, Risk Factors, and Disease Burden Jason E. Schillerstrom, Kimberly S. Benavente, and Ivelisse M. Velazquez-Negron 2. Diagnostic Interviewing and Cognitive ScreeningPhillip K. Martin, Kamalakar Surineni, and Ryan W. Schroeder 3. Neuropsychological AssessmentGabrielle A. Hromas and Jeremy J. Davis 4. Neurologic Exam Sethulakshmi Sreevalsam Anil and Badr Ratnakaran 5. Neuroimaging Mary A. Kelley and John A. Bertelson 6. Differential Diagnosis Emily J. MacKillop and Heather E. McNeely Section II: Age-Associated Neurocognitive Disorders7. Mild Cognitive Impairment Alec Neale, Jenna Axelrod, Elizabeth Geary, and Leslie M. Guidotti-Breting 8. Alzheimer's Disease Kyle J. Jennette and Jason R. Soble 9. Vascular Disease Seetha Chandrasekhara and Danna L. Zevy 10. Frontotemporal Lobular Degeneration Angelina J. Polsinelli, Dale Korinek, Elizabeth K. Vernon, and Sophia Wang 11. Lewy Body Disease and Atypical Parkinsonian Conditions Bonnie M. Scott and Jared F. Benge 12. Rare and Rapidly Progressive Dementias Joel E. Kamper, Emily N. VanDerBleek, and Erin K. Bailey 13. Dementia due to Other Medical Conditions Channing A. Sofko and Katya Nama Section III: Disease Management14. Risk Management Aaron Bonner-Jackson 15. Pharmacological Treatment Deanna Fernandes and Josepha Cheong 16. Non-pharmacological Approaches - Yesenia Serrano, Marie C. Weil, and Stephanie A. Tuncel 17. Safety Considerations Joseph J. Asper, Alyssa C. Smith, Angelina J. Polsinelli, and Sophia Wang 18. Palliative and Advanced Care Planning Adithy S. Nagarajan, Brian Donley, and Erica C. Garcia-Pittman 19. Legal Issues Senthil Vel Rajan Rajaram Manoharan MBBS, Jessy Walia, and Mack Bozman 20. Attending to the Caregiver Shannon Reilly, Brianna Daranciang, and Kathleen Fuchs

Dr Robin Hilsabeck is a board-certified clinical neuropsychologist who is Professor of Neurology and Division Chief of Clinical Neuropsychology at The University of Texas (UT) Health San Antonio and the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases. Previously, she was Director of the Comprehensive Memory Center, an interprofessional dementia specialty clinic, at UT Health Austin Mulva Clinic for the Neurosciences. Dr Hilsabeck's research has been funded by the National Institutes of Health, the Alzheimer's Association, and the Texas Alzheimer's Research and Care Consortium. She has over 80 publications and 130 workshop and conference presentations. Dr Gayle Ayers is Associate Professor in the Department of Psychiatry at Texas Tech University Health Sciences Center School of Medicine. She completed her psychiatry residency training at UT Southwestern in Dallas, TX, and a geriatric psychiatry fellowship at Yale University. She is board certified in both Adult andGeriatric Psychiatry. Dr Ayers previously worked for 8 years in Austin as an Assistant Professor in the both the Department of Psychiatry and Neurology at Dell Medical School and with Ascension Seton in Austin. She was the Medical Director for a geriatric clinic that served a broad Central Texas rural area. She has engaged in numerous talks and presentations to further community education regarding cognitive disorders.

• Introduction and OverviewRobin C. Hilsabeck and Gayle Ayers Section I: Core Concepts1. Epidemiology, Risk Factors, and Disease Burden Jason E. Schillerstrom, Kimberly S. Benavente, and Ivelisse M. Velazquez-Negron 2. Diagnostic Interviewing and Cognitive ScreeningPhillip K. Martin, Kamalakar Surineni, and Ryan W. Schroeder 3. Neuropsychological AssessmentGabrielle A. Hromas and Jeremy J. Davis 4. Neurologic Exam Sethulakshmi Sreevalsam Anil and Badr Ratnakaran 5. Neuroimaging Mary A. Kelley and John A. Bertelson 6. Differential Diagnosis Emily J. MacKillop and Heather E. McNeely Section II: Age-Associated Neurocognitive Disorders7. Mild Cognitive Impairment Alec Neale, Jenna Axelrod, Elizabeth Geary, and Leslie M. Guidotti-Breting 8. Alzheimer's Disease Kyle J. Jennette and Jason R. Soble 9. Vascular Disease Seetha Chandrasekhara and Danna L. Zevy 10. Frontotemporal Lobular Degeneration Angelina J. Polsinelli, Dale Korinek, Elizabeth K. Vernon, and Sophia Wang 11. Lewy Body Disease and Atypical Parkinsonian Conditions Bonnie M. Scott and Jared F. Benge 12. Rare and Rapidly Progressive Dementias Joel E. Kamper, Emily N. VanDerBleek, and Erin K. Bailey 13. Dementia due to Other Medical Conditions Channing A. Sofko and Katya Nama Section III: Disease Management14. Risk Management Aaron Bonner-Jackson 15. Pharmacological Treatment Deanna Fernandes and Josepha Cheong 16. Non-pharmacological Approaches - Yesenia Serrano, Marie C. Weil, and Stephanie A. Tuncel 17. Safety Considerations Joseph J. Asper, Alyssa C. Smith, Angelina J. Polsinelli, and Sophia Wang 18. Palliative and Advanced Care Planning Adithy S. Nagarajan, Brian Donley, and Erica C. Garcia-Pittman 19. Legal Issues Senthil Vel Rajan Rajaram Manoharan MBBS, Jessy Walia, and Mack Bozman 20. Attending to the Caregiver Shannon Reilly, Brianna Daranciang, and Kathleen Fuchs